Caxton Associates LP Acquires Shares of 100,000 Intuitive Surgical, Inc. (NASDAQ:ISRG)

Caxton Associates LP bought a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 100,000 shares of the medical equipment provider's stock, valued at approximately $52,196,000. Intuitive Surgical comprises about 1.6% of Caxton Associates LP's portfolio, making the stock its 11th largest position.

Other institutional investors also recently bought and sold shares of the company. Principal Financial Group Inc. boosted its stake in Intuitive Surgical by 1.5% during the 3rd quarter. Principal Financial Group Inc. now owns 602,393 shares of the medical equipment provider's stock valued at $295,938,000 after purchasing an additional 9,194 shares during the last quarter. World Investment Advisors LLC bought a new position in shares of Intuitive Surgical during the third quarter valued at $228,000. Synovus Financial Corp boosted its position in shares of Intuitive Surgical by 1.1% during the third quarter. Synovus Financial Corp now owns 2,572 shares of the medical equipment provider's stock valued at $1,264,000 after buying an additional 28 shares during the last quarter. Nordea Investment Management AB increased its holdings in Intuitive Surgical by 31.7% in the 4th quarter. Nordea Investment Management AB now owns 43,200 shares of the medical equipment provider's stock worth $22,632,000 after buying an additional 10,405 shares in the last quarter. Finally, Capital Market Strategies LLC raised its position in Intuitive Surgical by 7.8% in the 4th quarter. Capital Market Strategies LLC now owns 1,237 shares of the medical equipment provider's stock worth $646,000 after buying an additional 90 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Price Performance

Shares of ISRG stock traded up $2.64 during mid-day trading on Thursday, hitting $538.79. The company had a trading volume of 1,469,311 shares, compared to its average volume of 1,628,393. The company has a market capitalization of $193.11 billion, a P/E ratio of 84.05, a P/E/G ratio of 5.85 and a beta of 1.70. The stock's 50 day moving average price is $501.93 and its 200-day moving average price is $534.44. Intuitive Surgical, Inc. has a 52-week low of $379.67 and a 52-week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating the consensus estimate of $1.71 by $0.10. The business had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same quarter in the prior year, the firm earned $1.50 EPS. On average, equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 269 shares of Intuitive Surgical stock in a transaction on Monday, February 10th. The shares were sold at an average price of $590.00, for a total value of $158,710.00. Following the completion of the transaction, the chief financial officer now directly owns 3,282 shares of the company's stock, valued at $1,936,380. This trade represents a 7.58 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Jami K. Nachtsheim sold 2,400 shares of the company's stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the sale, the director now owns 6,371 shares in the company, valued at $3,312,920. This represents a 27.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 33,313 shares of company stock worth $17,229,143 in the last quarter. 0.70% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of analysts have recently commented on the stock. Erste Group Bank lowered shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research note on Monday, March 17th. Royal Bank of Canada cut their target price on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Jefferies Financial Group increased their price target on Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. BTIG Research set a $560.00 price objective on Intuitive Surgical and gave the stock a "buy" rating in a report on Monday, April 14th. Finally, Wells Fargo & Company upped their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the company an "overweight" rating in a research report on Friday, January 24th. Five research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat, Intuitive Surgical has a consensus rating of "Moderate Buy" and a consensus price target of $598.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.